Skip to main content
Caplight Logo









Ambulero, Inc.

Ambulero, Inc.

Private
Miami, FloridaHealthcare & Life Scienceshttps://ambulero.com

Last Round

VC Round

Jan 25, 2021

Company Overview

Ambulero, Inc. operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a VC Round in January 2021.

Ambulero, Inc. is a biotechnology company that develops cell and gene therapies for the treatment of vascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ambulero, Inc. Comparables

Compare Ambulero, Inc. with similar companies based on industry and business-model similarity.

Ambulero, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ixaka Ltd
84%
BioGenCell
84%
Libella Gene Therapeutics
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ambulero, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 25, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Ambulero, Inc. Investors

Notable investors and investment history

Ambulero, Inc. investors
InvestorRounds
Orphinic Scientific SAVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors increased 187% MoM.

  • Jan 25, 2021

    $5.5M round led by Orphinic Scientific SA

Book a demo to see all signals

For institutional investors. Book with your work email.

Ambulero, Inc. Filings

Explore SEC and related filing metadata, where available.

Ambulero, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ambulero, Inc.'s valuation, stock price, and market status.

Is Ambulero, Inc. a public or private company?

Ambulero, Inc. is a private company.

What is the current stock price of Ambulero, Inc.?

Ambulero, Inc. is a private company, so its shares have no public market price. Caplight tracks Ambulero, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ambulero, Inc. worth (valuation)?

Valuation information for Ambulero, Inc. is not publicly available.

Can I buy Ambulero, Inc. stock?

Ambulero, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ambulero, Inc.'s last funding round?

Ambulero, Inc.'s most recent funding round was VC Round on January 25, 2021.

Who are the main investors in Ambulero, Inc.?

Key investors in Ambulero, Inc. include Orphinic Scientific SA.

Will Ambulero, Inc. IPO soon?

No public IPO plans have been announced for Ambulero, Inc..

How can I track Ambulero, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Ambulero, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersMiami, Florida
Employee Range1
Year Founded2019
Last FundingJan 25, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?